10-K Filing

ALKERMES PLC. CIK: 1520262 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001564590-22-005304`
Period End Date	20211231
Filing Date	20220216
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	alks-10k_20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 65 Cash Flow Statement 106 Stockholders Equity 26

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Preferred stock shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock shares, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock shares, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$272.96M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$337.54M	USD	Point-in-time
Preferred stock shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$313.19M	USD	Point-in-time
Preferred stock shares, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$275.14M	USD	Point-in-time
Preferred stock shares, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investmentsshort-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$198.77M	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Investmentsshort-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$362.07M	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	450.00M	shares	Point-in-time
Inventory	`InventoryNet`	$150.34M	USD	Point-in-time
Inventory	`InventoryNet`	$125.74M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	450.00M	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	162.27M	shares	Point-in-time
Contract assets	`ContractWithCustomerAssetNetCurrent`	$14.40M	USD	Point-in-time
Contract assets	`ContractWithCustomerAssetNetCurrent`	$13.36M	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	165.79M	shares	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	159.16M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$60.66M	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	161.94M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$48.97M	USD	Point-in-time
Treasury shares	`TreasuryStockCommonShares`	3.85M	shares	Point-in-time
Treasury shares	`TreasuryStockCommonShares`	3.11M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.11B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.06B	USD	Point-in-time
PROPERTY, PLANT AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$350.00M	USD	Point-in-time
PROPERTY, PLANT AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$341.05M	USD	Point-in-time
INVESTMENTSLONG-TERM	`LongTermInvestments`	$24.78M	USD	Point-in-time
INVESTMENTSLONG-TERM	`LongTermInvestments`	$229.43M	USD	Point-in-time
RIGHT-OF-USE ASSETS	`OperatingLeaseRightOfUseAsset`	$131.72M	USD	Point-in-time
RIGHT-OF-USE ASSETS	`OperatingLeaseRightOfUseAsset`	$115.63M	USD	Point-in-time
INTANGIBLE ASSETS, NET	`FiniteLivedIntangibleAssetsNet`	$74.04M	USD	Point-in-time
INTANGIBLE ASSETS, NET	`FiniteLivedIntangibleAssetsNet`	$111.19M	USD	Point-in-time
GOODWILL	`Goodwill`	$92.87M	USD	Point-in-time
GOODWILL	`Goodwill`	$92.87M	USD	Point-in-time
DEFERRED TAX ASSETS	`DeferredIncomeTaxAssetsNet`	$81.83M	USD	Point-in-time
DEFERRED TAX ASSETS	`DeferredIncomeTaxAssetsNet`	$86.23M	USD	Point-in-time
CONTINGENT CONSIDERATION	`BusinessCombinationContingentConsiderationAssetNoncurrent`	$16.62M	USD	Point-in-time
CONTINGENT CONSIDERATION	`BusinessCombinationContingentConsiderationAssetNoncurrent`	$24.65M	USD	Point-in-time
OTHER ASSETS	`OtherAssetsNoncurrent`	$10.84M	USD	Point-in-time
OTHER ASSETS	`OtherAssetsNoncurrent`	$17.32M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.02B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.95B	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$445.71M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$412.17M	USD	Point-in-time
Operating lease liabilitiesshort-term	`OperatingLeaseLiabilityCurrent`	$16.24M	USD	Point-in-time
Operating lease liabilitiesshort-term	`OperatingLeaseLiabilityCurrent`	$15.73M	USD	Point-in-time
Contract liabilitiesshort-term	`ContractWithCustomerLiabilityCurrent`	$6.34M	USD	Point-in-time
Contract liabilitiesshort-term	`ContractWithCustomerLiabilityCurrent`	$7.51M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$2.84M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$471.29M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$438.26M	USD	Point-in-time
LONG-TERM DEBT	`LongTermDebtNoncurrent`	$272.12M	USD	Point-in-time
LONG-TERM DEBT	`LongTermDebtNoncurrent`	$292.80M	USD	Point-in-time
OPERATING LEASE LIABILITIESLONG-TERM	`OperatingLeaseLiabilityNoncurrent`	$119.46M	USD	Point-in-time
OPERATING LEASE LIABILITIESLONG-TERM	`OperatingLeaseLiabilityNoncurrent`	$104.16M	USD	Point-in-time
CONTRACT LIABILITIESLONG-TERM	`ContractWithCustomerLiabilityNoncurrent`	$11.49M	USD	Point-in-time
CONTRACT LIABILITIESLONG-TERM	`ContractWithCustomerLiabilityNoncurrent`	$16.40M	USD	Point-in-time
OTHER LONG-TERM LIABILITIES	`OtherLiabilitiesNoncurrent`	$32.16M	USD	Point-in-time
OTHER LONG-TERM LIABILITIES	`OtherLiabilitiesNoncurrent`	$36.51M	USD	Point-in-time
Total liabilities	`Liabilities`	$911.90M	USD	Point-in-time
Total liabilities	`Liabilities`	$882.75M	USD	Point-in-time
COMMITMENTS AND CONTINGENT LIABILITIES (Note 19)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENT LIABILITIES (Note 19)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at December 31, 2021 and 2020, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at December 31, 2021 and 2020, respectively	`PreferredStockValue`	-	USD	Point-in-time
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 165,790,549 and 162,269,220 shares issued; 161,937,327 and 159,161,141 shares outstanding at December 31, 2021 and 2020, respectively	`CommonStockValue`	$1.62M	USD	Point-in-time
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 165,790,549 and 162,269,220 shares issued; 161,937,327 and 159,161,141 shares outstanding at December 31, 2021 and 2020, respectively	`CommonStockValue`	$1.66M	USD	Point-in-time
Treasury shares, at cost (3,853,222 and 3,108,079 shares at December 31, 2021 and 2020, respectively)	`TreasuryStockCommonValue`	$126.09M	USD	Point-in-time
Treasury shares, at cost (3,853,222 and 3,108,079 shares at December 31, 2021 and 2020, respectively)	`TreasuryStockCommonValue`	$142.66M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.69B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.80B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.72M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.35M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.54B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.49B	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$1.07B	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$1.17B	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$1.09B	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$1.11B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$1.95B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$2.02B	USD	Point-in-time

Income Statement 65 line items

Line Item	Tag	Value	Unit	Period
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-706.00K	USD	Annual
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$130.00K	USD	Annual
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$426.00K	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.17B	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.17B	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.04B	USD	Annual
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsAndServicesSold`	$197.39M	USD	Annual
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsAndServicesSold`	$180.38M	USD	Annual
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsAndServicesSold`	$178.32M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$406.53M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$394.59M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$512.83M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$599.45M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$538.83M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$560.98M	USD	Annual
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$39.45M	USD	Annual
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$38.15M	USD	Annual
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$40.36M	USD	Annual
Restructuring expense	`RestructuringCharges`	$13.40M	USD	Annual
Restructuring expense	`RestructuringCharges`	$13.40M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.15B	USD	Annual
Total expenses	`CostsAndExpenses`	$1.20B	USD	Annual
Total expenses	`CostsAndExpenses`	$1.35B	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-29.29M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-112.43M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-175.48M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$6.96M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$13.98M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$2.41M	USD	Annual
Interest expense	`InterestExpense`	$8.66M	USD	Annual
Interest expense	`InterestExpense`	$13.60M	USD	Annual
Interest expense	`InterestExpense`	$11.22M	USD	Annual
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-22.80M	USD	Annual
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-1.43M	USD	Annual
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$3.94M	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$219.00K	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$848.00K	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$13.64M	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-10.02M	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-21.58M	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$15.89M	USD	Annual
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-96.54M	USD	Annual
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-39.31M	USD	Annual
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-197.06M	USD	Annual
INCOME TAX PROVISION (BENEFIT)	`IncomeTaxExpenseBenefit`	$-436.00K	USD	Annual
INCOME TAX PROVISION (BENEFIT)	`IncomeTaxExpenseBenefit`	$14.32M	USD	Annual
INCOME TAX PROVISION (BENEFIT)	`IncomeTaxExpenseBenefit`	$8.86M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-196.62M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-48.17M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-110.86M	USD	Annual
Basic and diluted (in dollars loss per ordinary share)	`EarningsPerShareBasicAndDiluted`	$-0.30	USD	Annual
Basic and diluted (in dollars loss per ordinary share)	`EarningsPerShareBasicAndDiluted`	$-1.25	USD	Annual
Basic and diluted (in dollars loss per ordinary share)	`EarningsPerShareBasicAndDiluted`	$-0.70	USD	Annual
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	157.05M	shares	Annual
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	160.94M	shares	Annual
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	158.80M	shares	Annual
Net loss	`NetIncomeLoss`	$-48.17M	USD	Annual
Net loss	`NetIncomeLoss`	$-110.86M	USD	Annual
Net loss	`NetIncomeLoss`	$-196.62M	USD	Annual
Holding (loss) gain, net of a tax (benefit) provision of $(706), $130 and $426, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$467.00K	USD	Annual
Holding (loss) gain, net of a tax (benefit) provision of $(706), $130 and $426, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.46M	USD	Annual
Holding (loss) gain, net of a tax (benefit) provision of $(706), $130 and $426, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.37M	USD	Annual
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-110.39M	USD	Annual
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-50.54M	USD	Annual
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-195.16M	USD	Annual

Cash Flow Statement 106 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-110.86M	USD	Annual
Net loss	`ProfitLoss`	$-196.62M	USD	Annual
Net loss	`ProfitLoss`	$-48.17M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$80.41M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$78.65M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$81.85M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$100.98M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$87.62M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$90.16M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$5.08M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$9.98M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-319.00K	USD	Annual
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-22.80M	USD	Annual
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-1.43M	USD	Annual
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$3.94M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-171.00K	USD	Annual
Payment made for debt modification	`PaymentsForRestructuring`	$97.00K	USD	Annual
Impairment of investment in Synchronicity Pharma, Inc.	`ImpairmentOfInvestments`	$977.00K	USD	Annual
Other non-cash charges	`OtherNoncashExpense`	$1.60M	USD	Annual
Other non-cash charges	`OtherNoncashExpense`	$2.51M	USD	Annual
Other non-cash charges	`OtherNoncashIncome`	$580.00K	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$-35.14M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$38.01M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$18.05M	USD	Annual
Contract assets	`IncreaseDecreaseInContractWithCustomerAsset`	$-6.04M	USD	Annual
Contract assets	`IncreaseDecreaseInContractWithCustomerAsset`	$6.01M	USD	Annual
Contract assets	`IncreaseDecreaseInContractWithCustomerAsset`	$5.16M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$22.93M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$24.77M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$13.08M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-4.02M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$1.78M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-11.48M	USD	Annual
Right-of-use assets	`IncreaseDecreaseInRightOfUseAsset`	$-17.34M	USD	Annual
Right-of-use assets	`IncreaseDecreaseInRightOfUseAsset`	$-17.05M	USD	Annual
Right-of-use assets	`IncreaseDecreaseInRightOfUseAsset`	$-8.40M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$50.60M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$29.85M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$34.85M	USD	Annual
Contract liabilities	`IncreaseDecreaseInContractWithCustomerLiability`	$16.14M	USD	Annual
Contract liabilities	`IncreaseDecreaseInContractWithCustomerLiability`	$-4.92M	USD	Annual
Contract liabilities	`IncreaseDecreaseInContractWithCustomerLiability`	$-6.08M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-16.27M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-16.78M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-9.12M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$9.37M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-4.33M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$18.00K	USD	Annual
Cash flows provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$101.72M	USD	Annual
Cash flows provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$82.84M	USD	Annual
Cash flows provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$72.08M	USD	Annual
Additions of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$42.22M	USD	Annual
Additions of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$90.94M	USD	Annual
Additions of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$28.02M	USD	Annual
Proceeds from the sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$900.00K	USD	Annual
Proceeds from the sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$287.00K	USD	Annual
Proceeds from the sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$643.00K	USD	Annual
Proceeds from contingent consideration	`ProceedsFromContingentConsideration`	$3.89M	USD	Annual
Proceeds from contingent consideration	`ProceedsFromContingentConsideration`	$10.00M	USD	Annual
Proceeds from contingent consideration	`ProceedsFromContingentConsideration`	$7.94M	USD	Annual
Return of Fountain Healthcare Partners II, L.P. investment	`ReturnOfInvestments`	$2.75M	USD	Annual
Payment made for licensed Intellectual Property ("IP")	`PaymentMadeForLicensedIntellectualProperty`	$1.00M	USD	Annual
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$340.42M	USD	Annual
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$229.54M	USD	Annual
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$277.52M	USD	Annual
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$253.00M	USD	Annual
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$295.01M	USD	Annual
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$224.60M	USD	Annual
Acquisition of Rodin Therapeutics, Inc.'s net assets, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$8.88M	USD	Annual
Cash flows used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-141.83M	USD	Annual
Cash flows used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.48M	USD	Annual
Cash flows used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-66.20M	USD	Annual
Proceeds from the issuance of ordinary shares under share-based compensation arrangements	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$18.93M	USD	Annual
Proceeds from the issuance of ordinary shares under share-based compensation arrangements	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$25.32M	USD	Annual
Proceeds from the issuance of ordinary shares under share-based compensation arrangements	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$8.37M	USD	Annual
Employee taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$16.57M	USD	Annual
Employee taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$9.32M	USD	Annual
Employee taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$7.70M	USD	Annual
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$23.57M	USD	Annual
Payment made for debt extinguishment	`PaymentsOfDebtExtinguishmentCosts`	$993.00K	USD	Annual
Principal payments of long-term debt	`RepaymentsOfLongTermDebt`	$2.84M	USD	Annual
Principal payments of long-term debt	`RepaymentsOfLongTermDebt`	$2.84M	USD	Annual
Principal payments of long-term debt	`RepaymentsOfLongTermDebt`	$2.25M	USD	Annual
Cash flows provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.76M	USD	Annual
Cash flows provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.17M	USD	Annual
Cash flows provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$29.07M	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$69.19M	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$64.58M	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-62.99M	USD	Annual
CASH AND CASH EQUIVALENTSBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$337.54M	USD	Point-in-time
CASH AND CASH EQUIVALENTSBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$203.77M	USD	Point-in-time
CASH AND CASH EQUIVALENTSBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$266.76M	USD	Point-in-time
CASH AND CASH EQUIVALENTSBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$272.96M	USD	Point-in-time
CASH AND CASH EQUIVALENTSEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$266.76M	USD	Point-in-time
CASH AND CASH EQUIVALENTSEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$272.96M	USD	Point-in-time
CASH AND CASH EQUIVALENTSEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$337.54M	USD	Point-in-time
CASH AND CASH EQUIVALENTSEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$203.77M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$8.29M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$13.25M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$6.90M	USD	Annual
Cash paid for taxes	`IncomeTaxesPaid`	$620.00K	USD	Annual
Cash paid for taxes	`IncomeTaxesPaid`	$2.51M	USD	Annual
Cash paid for taxes	`IncomeTaxesPaid`	$1.89M	USD	Annual
Purchased capital expenditures included in accounts payable and accrued expenses	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$2.42M	USD	Annual
Purchased capital expenditures included in accounts payable and accrued expenses	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$6.03M	USD	Annual
Purchased capital expenditures included in accounts payable and accrued expenses	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$13.79M	USD	Annual

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Tax provision (benefit)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-706.00K	USD	Annual
Tax provision (benefit)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$130.00K	USD	Annual
Tax provision (benefit)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$426.00K	USD	Annual
BALANCE	`StockholdersEquity`	$1.07B	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.17B	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.09B	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.11B	USD	Point-in-time
Issuance of ordinary shares under employee stock plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$25.32M	USD	Annual
Issuance of ordinary shares under employee stock plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$8.37M	USD	Annual
Issuance of ordinary shares under employee stock plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$18.93M	USD	Annual
Receipt of Alkermes' shares for the purchase of stock options or to satisfy minimum tax withholding obligations related to share-based awards	`ReceiptOfCompanyStockForPurchaseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue`	$-9.32M	USD	Annual
Receipt of Alkermes' shares for the purchase of stock options or to satisfy minimum tax withholding obligations related to share-based awards	`ReceiptOfCompanyStockForPurchaseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue`	$-16.57M	USD	Annual
Receipt of Alkermes' shares for the purchase of stock options or to satisfy minimum tax withholding obligations related to share-based awards	`ReceiptOfCompanyStockForPurchaseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue`	$-7.70M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$91.26M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$99.70M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$87.40M	USD	Annual
Unrealized gain (loss) on marketable securities, net of tax provision (benefit)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.46M	USD	Annual
Unrealized gain (loss) on marketable securities, net of tax provision (benefit)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$467.00K	USD	Annual
Unrealized gain (loss) on marketable securities, net of tax provision (benefit)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.37M	USD	Annual
Net loss	`NetIncomeLoss`	$-48.17M	USD	Annual
Net loss	`NetIncomeLoss`	$-110.86M	USD	Annual
Net loss	`NetIncomeLoss`	$-196.62M	USD	Annual
BALANCE	`StockholdersEquity`	$1.09B	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.07B	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.17B	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.11B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.